The American Pharmacogenomics Association (APGxA) today issued a statement on the Food and Drug Administration’s (FDA) final rule regarding the regulation of laboratory-developed tests (LDTs).
Discover why some medications may not work for you through pharmacogenomics, the key to personalized medicine and better drug efficacy.
The American Pharmacogenomics Association (APGxA), a pivotal organization dedicated to the advancement of pharmacogenomics, is proud to announce its recognition as the #1 Best Precision Medicine Blog and Website in 2024 by Feedspot.
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx